These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 25423769)
1. Hepatitis C treatment: improved efficacy and tolerability. Lemon M S D Med; 2014 Oct; 67(10):419-20. PubMed ID: 25423769 [No Abstract] [Full Text] [Related]
2. [Hepatitis C--the misdiagnosed epidemic. Chances for healing are available--use them!]. Westphal K MMW Fortschr Med; 2006 Apr; 148(16):4-6, 8. PubMed ID: 16688938 [No Abstract] [Full Text] [Related]
3. [Characteristics of hepatitis and influenza antivirals: update 2009]. Lopez-Suñé E; Tuset M; Laguno M; Moreno A; Miró JM Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):253.e1-17. PubMed ID: 20395018 [TBL] [Abstract][Full Text] [Related]
4. New strategies in the treatment of hepatitis C. Bean P Am Clin Lab; 2002 Apr; 21(3):18-20. PubMed ID: 12038080 [No Abstract] [Full Text] [Related]
5. [Hepatitis C. An increase in interferon-free therapy]. Warpakowski A MMW Fortschr Med; 2014 Jun; 156 Suppl 1():8. PubMed ID: 25026844 [No Abstract] [Full Text] [Related]
6. Acute hepatitis C treatment. Lerias de Almeida PR Ann Hepatol; 2010; 9 Suppl():107-11. PubMed ID: 20714006 [TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis C in the setting of liver transplantation. Khalid SK; Crippin JS Clin Liver Dis; 2006 May; 10(2):321-37, ix. PubMed ID: 16971264 [TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent hepatitis C post-liver transplantation. Marroni CA Ann Hepatol; 2010; 9 Suppl():84-91. PubMed ID: 20714002 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection]. Bani-Sadr F Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917 [No Abstract] [Full Text] [Related]
10. New pharmacotherapy for hepatitis C. Assis DN; Lim JK Clin Pharmacol Ther; 2012 Sep; 92(3):294-305. PubMed ID: 22850602 [TBL] [Abstract][Full Text] [Related]
11. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain. Yachimski P; Chung RT AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393 [No Abstract] [Full Text] [Related]
12. [Viral hepatitis B/C and HIV. Therapy of double infections]. Mauss S MMW Fortschr Med; 2003 Apr; 145 Spec No 1():21-5. PubMed ID: 15011579 [TBL] [Abstract][Full Text] [Related]
14. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C]. García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422 [No Abstract] [Full Text] [Related]
15. An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there! Rubin A; Berenguer M Liver Transpl; 2010 Jun; 16(6):697-700. PubMed ID: 20517902 [No Abstract] [Full Text] [Related]
16. Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al. De Vita S; Quartuccio L Arthritis Rheum; 2010 Mar; 62(3):908-9; author reply 909. PubMed ID: 20131242 [No Abstract] [Full Text] [Related]
17. Hepatitis C Virus in the HIV-infected patient. Andersson K; Chung RT Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263 [TBL] [Abstract][Full Text] [Related]